HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (27) Citing Articles via Google Scholar Google Scholar Articles by D’Orazio, P. Search for Related Content PubMed PubMed Citation Articles by D’Orazio, P. Related Collections Laboratory Management General Clinical Chemistry Point-of-Care Testing Endocrinology and Metabolism

Approved IFCC Recommendation on Reporting Results for Blood Glucose (Abbreviated)

¹ Instrumetation Laboratory, Lexington, MA.
² Hartford Hospital, Hartford, CT.
³ Herlev Hospital, Herlev, Denmark.
⁴ Wadsworth Center, Albany, NY.
⁵ University of Tsukuba, Tsukuba, Japan.
⁶ Medizinizche Hochschule, Hannover, Germany.
⁷ Univeristy of Linköping, Linköping, Sweden.
⁸ Åbo Akademi University, Åbo-Turku, Finland.
⁹ Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands.
¹⁰ Fresenius, Bad Homburg, Germany.
¹¹ Jagiellonian University, Krakow, Poland.
¹² Department of Pathology, University of Texas Medical Branch, Galveston, TX.

^aAddress correspondence to this author at: Department of Clinical Biochemistry, Herlev Hospital, DK-2730 Herlev, Denmark. E-mail nifa{at}herlevhosp.kbhamt.dk.

In current clinical practice, plasma and blood glucose are used interchangeably with a consequent risk of clinical misinterpretation. In human blood, glucose, like water, is distributed between erythrocytes and plasma. The molality of glucose (amount of glucose per unit of water mass) is the same throughout the sample, but the concentration is higher in plasma because the concentration of water and, therefore, glucose is higher in plasma than in erythrocytes. Different devices for the measurement of glucose may detect and report fundamentally different quantities. Different water concentrations in calibrators, plasma, and erythrocyte fluid can explain some of the differences. Results of glucose measurements depend on sample type and on whether methods require sample dilution or use biosensors in undiluted samples. If the results are mixed up or used indiscriminately, the differences may exceed the maximum allowable error of glucose determinations for diagnosing and monitoring diabetes mellitus, and complicate the treatment. The goal of the IFCC Scientific Division Working Group on Selective Electrodes and Point of Care Testing (IFCC-SD, WG-SEPOCT) is to reach a global consensus on reporting results. The document recommends reporting the concentration of glucose in plasma (with the unit mmol/L), irrespective of sample type or measurement technique. A constant factor of 1.11 is used to convert concentration in whole blood to the equivalent concentration in the pertinent plasma. The conversion will provide harmonized results, facilitating the classification and care of patients and leading to fewer therapeutic misjudgments.

The following articles in journals at HighWire Press have cited this article:

				H. A. Bergrem, T. G. Valderhaug, A. Hartmann, H. Bergrem, J. Hjelmesaeth, and T. Jenssen Glucose tolerance before and after renal transplantation Nephrol. Dial. Transplant., October 23, 2009; (2009) gfp566v1. [Abstract] [Full Text] [PDF]

				C. Florkowski, C. Budgen, D. Kendall, H. Lunt, and M P. Moore Comparison of blood glucose meters in a New Zealand diabetes centre Ann Clin Biochem, July 1, 2009; 46(4): 302 - 305. [Abstract] [Full Text] [PDF]

				J. J. Meier, B. A. Menge, T. G.K. Breuer, C. A. Muller, A. Tannapfel, W. Uhl, W. E. Schmidt, and H. Schrader Functional Assessment of Pancreatic {beta}-Cell Area in Humans Diabetes, July 1, 2009; 58(7): 1595 - 1603. [Abstract] [Full Text] [PDF]

				E. S. Moghissi, M. T. Korytkowski, M. DiNardo, D. Einhorn, R. Hellman, I. B. Hirsch, S. E. Inzucchi, F. Ismail-Beigi, M. S. Kirkman, and G. E. Umpierrez American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control Diabetes Care, June 1, 2009; 32(6): 1119 - 1131. [Full Text] [PDF]

				C. Strom Moller, B. Zethelius, J. Sundstrom, and L. Lind Persistent ischaemic ECG abnormalities on repeated ECG examination have important prognostic value for cardiovascular disease beyond established risk factors: a population-based study in middle-aged men with up to 32 years of follow-up Heart, September 1, 2007; 93(9): 1104 - 1110. [Abstract] [Full Text] [PDF]

				K. Dungan, J. Chapman, S. S. Braithwaite, and J. Buse Glucose Measurement: Confounding Issues in Setting Targets for Inpatient Management Diabetes Care, February 1, 2007; 30(2): 403 - 409. [Full Text] [PDF]

				M. W. Steffes and D. B. Sacks Measurement of Circulating Glucose Concentrations: The Time Is Now for Consistency among Methods and Types of Samples Clin. Chem., September 1, 2005; 51(9): 1569 - 1570. [Full Text] [PDF]